secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2026-04-08T23:59:59+00:00
Accession:  0000718937-26-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical prelim Q1 2026 net sales expected >$90M, up from $42.6M YoY
--------------------------------------------------------------------------

- Net sales expected to exceed $90M in Q1 2026, more than double prior year's $42.6M.
- China accounted for majority of increase; Americas delivered double-digit growth.
- Significant cost-structure improvement expected to drive meaningful adjusted EBITDA increase.
- Middle East & parts of EMEA/APAC saw sales decline due to geopolitical/macro headwinds.
- Full Q1 results and 10-Q to be reported in early May; no forward guidance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000071893726000009/0000718937-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000071893726000009/staa-20260408.htm
  HTML page:      https://secwatch.observer/filing/0000718937-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer